Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3]neurotensin binding sites within the ventral midbrain and striatum

European Journal of Pharmacology

Volumn 539, Issue 3, 2006, Pages 158-163

  Radja, Fatiha ^a   Bauco, Pat ^a   Rompré, Pierre Paul ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Dopamine; Excitotoxic lesion; Neurotensin; Prefrontal cortex; Striatum

Indexed keywords

IBOTENIC ACID; IODINE 125; LEVOCABASTINE; NEUROTENSIN; NEUROTENSIN RECEPTOR; TYROSINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN NUCLEUS; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; EXCITOTOXICITY; MALE; MESENCEPHALON; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; BINDING SITES; CORPUS STRIATUM; EXCITATORY AMINO ACID AGONISTS; IODINE RADIOISOTOPES; MALE; MESENCEPHALON; PREFRONTAL CORTEX; RATS; RATS, LONG-EVANS; RECEPTORS, NEUROTENSIN; TYROSINE;

EID: 33646885705     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.060     Document Type: Article

References (40)

1. Alexander M.J., and Leeman S.E. Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor. J. Comp. Neurol. 402 (1998) 475-500
2. Berod A., and Rostene W. Neurotensin: an endogenous psychostimulant?. Curr. Opin. Pharmacol. 2 (2002) 93-98
3. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol. Rev. 53 (2001) 453-486
4. Blackburn A., Dewar K.M., Bauco P., and Rompré P.-P. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation. Brain Res. 998 (2004) 184-193
5. Boudin H., Pelaprat D., Rostene W., and Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373 (1996) 76-89
6. Boudin H., Pelaprat D., Rostene W., Pickel V.M., and Beaudet A. Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J. Neurosci. 18 (1998) 8473-8484
7. Cadet J.L., Kujirai K., and Przedborski S. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study. Brain Res. 564 (1991) 37-44
8. Cador M., Bjijou Y., Cailhol S., and Stinus L. d-Amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94 (1999) 705-721
9. Chalon P., Vita N., Kaghad M., Guillemot M., Bonnin J., Delpech B., Le Fur G., Ferrara P., and Caput D. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett. 386 (1996) 91-94
10. Delle Donne K.T., Chan J., Boudin H., Pelaprat D., Rostene W., and Pickel V.M. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell. Synapse 52 (2004) 176-187
11. 1-like receptors in the ventral tegmental area. Eur. J. Pharmacol. 336 (1997) 155-158
12. Goedert M., Pittaway K., and Emson P.C. Neurotensin receptors in the rat striatum: lesion studies. Brain Res. 299 (1984) 164-168
13. Kalivas P.W., and Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10 (1990) 2940-2949
14. Kalivas P.W., Nemeroff C.B., and Prange A.J.J. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur. J. Pharmacol. 78 (1982) 471-474
15. Kalivas P.W., Nemeroff C.B., and Prange A.J.J. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 11 (1984) 919-930
16. Kinkead B., and Nemeroff C.B. Neurotensin: an endogenous antipsychotic?. Curr. Opin. Pharmacol. 2 (2002) 99-103
17. Kitabgi P., Rostene W., Dussaillant M., Schotte A., Laduron P.M., and Vincent J.P. Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur. J. Pharmacol. 140 (1987) 285-293
18. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., and Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 273 (1998) 26273-26276
19. Nicot A., Rostene W., and Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341 (1994) 407-419
20. Nouel D., Faure M.-P., St.Pierre J.-A., Alonso R., Quirion R., and Beaudet A. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. J. Neurosci. 17 (1997) 1795-1803
21. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4 ed. (1998), Academic Press, San Diego
22. Petrie K.A., Schmidt D., Bubser M., Fadel J., Carraway R.E., and Deutch A.Y. Neurotensin activates GABAergic interneurons in the prefrontal cortex. J. Neurosci. 25 (2005) 1629-1636
23. Pickel V.M., Chan J., Delle Donne K.T., Boudin H., Pelaprat D., and Rostene W. High-affinity neurotensin receptors in the rat nucleus accumbens: subcellular targeting and relation to endogenous ligand. J. Comp. Neurol. 435 (2001) 142-155
24. Robledo P., Maldonado R., and Koob G.F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622 (1993) 105-112
25. Rompré P.-P. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. Peptides 16 (1995) 1417-1420
26. Rompré P.-P., Bauco P., and Gratton A. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin (1-13). Eur. J. Pharmacol. 211 (1992) 295-303
27. Rompré P.-P., Boye S.M., and Moisan J. Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing. Eur. J. Pharmacol. 341 (1998) 169-172
28. Santucci V., Gueudet C., Steinberg R., Le Fur G., and Soubrié P. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade. Synapse 26 (1997) 370-380
29. Sarret P., Perron A., Stroh T., and Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J. Comp. Neurol. 461 (2003) 520-538
30. Schotte A., and Leysen J.E. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain. J. Chem. Neuroanat. 2 (1989) 253-257
31. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 (1992) 145-160
32. Sesack S.R., Deutch A.Y., Roth R.H., and Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290 (1989) 213-242
33. 11]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens. Neuroscience 98 (2000) 485-492
34. 11]neurotensin on mesolimbic dopaminergic function. Neuropeptides 28 (1995) 43-50
35. Szigethy E., and Beaudet A. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study. J. Comp. Neurol. 279 (1989) 128-137
36. Tanaka K., Masu M., and Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4 (1990) 847-854
37. Tyler B.M., Groshan K., Cusack B., and Richelson E. In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinocoception. Brain Res. 787 (1998) 78-84
38. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51 (2004) 32-58
39. Vita N., Laurent P., Lefort S., Chalon P., Dumont X., Kaghad M., Gully D., Le F.G., Ferrara P., and Caput D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 317 (1993) 139-142
40. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., and White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-d-aspartate antagonists. Neuroscience 69 (1995) 417-439